Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral resistance testing.

Current opinion in infectious diseases - 1 Dec 2014

Smit Erasmus

Abstract excerpt

PURPOSE OF REVIEW: Current genotypic resistance tests fail to amplify drug-resistant minority variants when they are present below 20% of the total virus population. Next-generation sequencing (NGS) addresses this issue and is being introduced into diagnostic laboratories. This review gives an overview of the resistance tests currently used and explores the opportunities and challenges that NGS genotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Cytomegalovirus Infections
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis C

Share to Molecular Diagnostic Techniques

Share to Sensitivity and Specificity

Share to Viral Tropism

Source

Identifiers

PMID: 25313501
DOI: 10.1097/QCO.0000000000000108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiviral resistance testing.PMID 25313501Read ↗

Practical updates in clinical antiviral resistance testing.Semantic proximity Read ↗

Genotypic resistance testing in routine clinical care.Semantic proximity Read ↗

Next-generation sequencing reveals major and minority HIV-1 drug resistance mutations in treatment-experienced individuals with virological failure.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

Minority variants of drug-resistant HIV.Semantic proximity Read ↗

Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitorsSemantic proximity Read ↗

Resistance testing comes of age.Semantic proximity Read ↗

Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase InhibitorsSemantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

Primary HIV-1 Drug Resistant Minority Variants.Semantic proximity Read ↗

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment FailureSemantic proximity Read ↗

HIV resistance testing: methods, utility, and limitations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.